Piz Sardona

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors

Retrieved on: 
Wednesday, April 17, 2024

Mr. Babler, a highly successful executive who brings valuable industry experience to 89bio, currently serves as President, Chief Executive Officer and Chairman of the Board of Alumis Therapeutics.

Key Points: 
  • Mr. Babler, a highly successful executive who brings valuable industry experience to 89bio, currently serves as President, Chief Executive Officer and Chairman of the Board of Alumis Therapeutics.
  • “As 89bio executes on its ongoing Phase 3 programs for pegozafermin, this is an opportune time to add an industry leader like Martin to our board,” said Rohan Palekar, Chief Executive Officer of 89bio.
  • Mr. Babler previously served at Eli Lilly and Company in positions focused on sales, sales management, global marketing, and business development.
  • I am excited to work alongside the management team and Board of Directors to bring pegozafermin to the many patients in need.”

Jeremy Caldwell, Ph.D., Accomplished Biopharma Executive, Company Creator and R&D Leader, Joins Red Tree Venture Capital as Partner

Retrieved on: 
Thursday, November 16, 2023

SAN FRANCISCO, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Red Tree Venture Capital (“Red Tree”), a West Coast-centric, early stage-biased life science venture capital firm, today announced that Jeremy Caldwell, Ph.D., a widely respected biopharmaceutical executive and research and development leader, whose accomplishments span from the creation of innovative drug development companies to driving the discovery, development and translation of novel therapies, has joined the firm as a partner. Dr. Caldwell brings Red Tree a range of deep industry expertise built throughout a career involving roles as a member of both industry and the venture community. In alignment with the firm’s West Coast focus, he has forged deep ties within the San Diego and San Francisco Bay Area biotechnology communities.

Key Points: 
  • Dr. Caldwell brings Red Tree a range of deep industry expertise built throughout a career involving roles as a member of both industry and the venture community.
  • Based in San Diego, Dr. Caldwell’s addition to Red Tree illustrates the firm’s increased emphasis on targeting company creation and investment opportunities emanating from the greater San Diego area.
  • “Jeremy has led an accomplished career in the biopharmaceutical space, achieving impressive successes from the perspectives of executive, R&D leader, and company builder.
  • He currently serves as a member of the board of Red Tree portfolio companies Sardona Therapeutics and Biograph 55.

Tammy Ketura Announces the Releases of New International Collaborative Project, "I AM"

Retrieved on: 
Friday, April 30, 2021

Shame can impede the much-needed healing.\nIn the international collaborative project by Tammy Ketura, we focus exactly on the inter-contexts of Narcissistic Abuse Syndrome, Financial Poverty, and Self-Healing.\n"The concept for the project came to me while I was hiking in the UNESCO World Heritage Site of Sardona, Switzerland in July 2020.

Key Points: 
  • Shame can impede the much-needed healing.\nIn the international collaborative project by Tammy Ketura, we focus exactly on the inter-contexts of Narcissistic Abuse Syndrome, Financial Poverty, and Self-Healing.\n"The concept for the project came to me while I was hiking in the UNESCO World Heritage Site of Sardona, Switzerland in July 2020.
  • I was hiking, and pondering what clients were telling me; I need to heal and I don\'t have the money to heal.
  • I notice how the concept "I need money to heal" was also a major blocker on my own healing journey.
  • Here you write the 15th chapter.\nThe #1 International Bestseller can be purchased at IAmReleasingShame.org .